Dr. Andreas Weiler
SAFC Lives presents personnel profiles where we talk to the people who make SAFC tick to find out more about their personalities, position, what drives them, and what they enjoy doing when they are not playing a critical role in the ongoing growth of SAFC.
In this edition, we talk with Dr. Andreas Weiler, Strategic Marketing Manager of Pharma Contract Manufacturing Services in Buchs, Switzerland.
Last week, BioReliance President, Charlie Harwood shared information about the background of the company before it was purchased by Sigma-Aldrich, and a bit about what sets it apart. As we revisit the topic this week, Charlie offers a further look into the technologies behind the business and the future of the industry. (more…)
Welcome to another posting of ‘Industry Insight with Chester’, a periodic round-up of news and views from around the Pharma and biopharma industries compiled by Chester Solack, Business Analyst at SAFC in Lenexa, Kansas.
Life Science Leader's Chief Editor, Rob Wright, meets up with SAFC's Sobia Nayyar and Gilles Cottier at SAFC's media breakfast during CPhI Worldwide 2012 in Madrid.
Announced in the October edition of Life Science Leader, SAFC has been recognized as a multiple 2012 CMO Leadership Award Winner. Recipients of the CMO Leadership Awards are selected as a result of an independent study including more than 2700 industry peers from pharmaceutical and biopharmaceutical companies using CMO services. Out of a pool of more than 200 CMOs, SAFC was an award winner in four categories: innovation (business will enhance by in-house capabilities through a new idea, method, or device); productivity (business will deliver on agreed objectives); regulatory (business is reputable and compliant); and reliability (business will meet all project milestones and timelines).
“To be recognized by our customers in four out of five categories is a testament to the tremendous efforts that have been made in our CMO offering over the last 12 months,” stated Sobia Nayyar, SAFC’s Global Market Segment Manager, CMO. “Our goal is to be recognized as the supplier of choice to our pharmaceutical and biopharmaceutical customers. We are continually striving for improvement and will be putting a great deal of energy into that. However, attaining these prestigious awards is confirmation that we are on the right path and our customers appreciate the efforts made by all at SAFC.”
SAFC’s Gilles Cottier and Sobia Nayyar meet with Life Science Leader’s Chief Editor, Rob Wright, at this year Media Breakfast at CPhI Worldwide in Madrid.
World leaders in the antibody-drug conjugate field are descending upon San Francisco next week for the third annual World ADC Summit. SAFC, one of a handful of companies sponsoring the event will be exhibiting and also providing a key technical presentation during the summit. The presentation entitled “Manufacturing of ADCs, from Pre-Clinical to Commercial Scale,” will be delivered by SAFC’s manager of process development, Michael Bienkowski on Thursday, 25th October at 10.30am
The presentation will focus on ADC process development, analytical development and how to build compliant GMP manufacturing campaigns.
The presentation will also be available on SAFC Live following the summit. For further information on SAFC’s activities during the summit please contact Tim Malloy at tim.malloy@sial.com
For more information on SAFC’s antibody drug conjugate offering please visit http://www.safcglobal.com/safc-pharma/en-us/home/complex-emerging-technologies/bioconjugation.html
For more information on the ADC Summit 2012 please visit http://adc-summit.com/
Amanda Peterson, Product Manager and Dan Flowers, Product Manager at the SAFC booth at BPI 2012
SAFC has been onsite in Providence at the annual BioProcess International (BPI) Show. The team has enjoyed being among the positive buzz at the event, and is looking forward to the following presentations.
Technology Workshop, Thursday, October 11 at 12:00 p.m.
The CHOZN® Platform: Development and Testing Approaches to Enhance Therapeutic Processes
Kevin Kayser, Director, CHOZN Product Development, SAFC and Audrey Chang, Ph.D., Senior Director, Development Services, BioReliance
Podium Presentation, Friday, October 12 at 11:15 a.m.
Over-Expression of Protease Inhibitor Leads to Increase in Growth and lgG Production in CHO Cells
Nan Lin, Ph.D., Principal R&D Scientist, Cell Sciences and Development, SAFC
To learn more about SAFC, please visit the following sites:
• CHOZN Platform – A complete cell line solution that accelerates development timelines
• PharmaGrade Products – Raw materials with full documentation and supply chain transparency
• BioReliance cell & virus characterization
• Centers of Excellence for your liquid and powder cGMP products
Welcome to another posting of ‘Industry Insight with Chester’, a periodic round-up of news and views from around the Pharma and biopharma industries compiled by Chester Solack, Business Analyst at SAFC in Lenexa, Kansas.
